Number of subjects experiencing an increase in spasticity
| Result | Placebo, n = 20 | IFN, n = 30 | IFN 30 µg, n = 15 | IFN 60 µg, n = 15 |
|---|---|---|---|---|
| n, number; IFN, interferon beta-1a. | ||||
| All statistical comparisons not significant (p>0.05) except *p = 0.005. | ||||
| Sustained increase in spasticity | 13 | 11 | 9 | 2* |
| Post-dose spasticity | 3 | 10 | 4 | 6 |
| Increase in medication | 6 | 4 | 3 | 1 |